抗体-药物结合剂作为膀癌的游戏变革者:目前的进展和未来的方向
1Department of Urology Surgery, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China.
Frontiers in immunology
|May 28, 2025
概括
抗体-药物合物 (ADCs) 通过精确向瘤细胞,对膀癌治疗具有前途. 分析了研究趋势和NECTIN-4和HER2等关键目标,强调了尽管存在挑战,但未来的潜力.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 抗体-药物合物 (ADC) 提供向的癌症治疗.
- 膀癌的复发率很高,治疗选择有限.
- ADCs向与瘤相关的抗原,如NECTIN-4和HER2.
研究的目的:
- 评估目前用于膀癌的ADC疗法.
- 分析作用机制,临床疗效和安全性.
- 评估在膀癌中ADC研究的不断变化的格局.
主要方法:
- 从2004年至2025年期间对232项临床试验进行了系统分析.
- 在FDA批准Enfortumab vedotin后检查的趋势.
- 确定了关键的分子目标和地理研究分布.
主要成果:
- 自2019年以来,ADC研究的显著上升趋势.
- HER2,NECTIN4和PD-1是主要的目标.
- 美国和中国在ADC临床试验方面处于领先地位;组合疗法越来越受到人们的兴趣.
结论:
- ADCs在膀癌中表现出显著的疗效.
- 挑战包括毒性,患者分层和试验设计.
- 持续创新对于推进ADC治疗和改善患者治疗结果至关重要.
更多相关视频
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.4K
08:53In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
9.1K
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K